Ceftazidime
Ceftazidime for Injection, USP
Approved
Approval ID
112c5457-8d71-49f5-b531-9761d7d38c93
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2020
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 796852890
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ceftazidime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-127
Application NumberANDA062640
Product Classification
M
Marketing Category
C73584
G
Generic Name
ceftazidime
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJune 6, 2018
FDA Product Classification
INGREDIENTS (2)
ceftazidimeActive
Quantity: 1 g in 1 1
Code: 9M416Z9QNR
Classification: ACTIM
sodium carbonateInactive
Code: 45P3261C7T
Classification: IACT
ceftazidime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-128
Application NumberANDA062640
Product Classification
M
Marketing Category
C73584
G
Generic Name
ceftazidime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 6, 2018
FDA Product Classification
INGREDIENTS (2)
ceftazidimeActive
Quantity: 2 g in 1 1
Code: 9M416Z9QNR
Classification: ACTIM
sodium carbonateInactive
Code: 45P3261C7T
Classification: IACT